Application 050739
- Type
- NDA
- Sponsor
- ABBVIE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OMNICEF | CEFDINIR | CAPSULE;ORAL | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050739-001 | OMNICEF | CEFDINIR | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 1997-12-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N050739-001 | OMNICEF | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 1997-12-04 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N050739-001 | OMNICEF | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 1997-12-04 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N050739-001 | OMNICEF | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 1997-12-04 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N050739-001 | OMNICEF | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 1997-12-04 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals, Inc. | 5a72e445-b920-b97d-e063-6294a90af2ee | 2026-09-01 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | REMEDYREPACK INC. | a8029f7c-6353-46db-8c8c-c86a9485a14f | 2026-08-28 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | A-S Medication Solutions | 0eeac6df-bad7-413e-8b41-0660f3a99373 | 2026-08-20 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Northwind Health Company, LLC | 1d0d50ba-8c2b-855c-e063-6394a90a5c7d | 2026-07-09 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Proficient Rx LP | 63d2f931-6896-47e5-905e-4f812d6cb105 | 2026-06-01 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals, Inc. | 5128dc70-f3cd-25c0-e063-6294a90aa52f | 2026-05-06 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 3714d558-cbaa-42e8-831b-ffbbc951ebf2 | 2026-04-21 | Warnings | CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 5b6c1b5d-a1d5-4e08-9077-2af3f38fea4e | 2026-03-24 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | c3892cd7-0e98-4ba3-a845-4aedf6c2a830 | 2026-03-24 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 2da6eb80-63b0-4377-8d7b-865733ebbab1 | 2026-03-24 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 0d1212c9-604f-4999-8f7d-e7cf300705ef | 2026-03-24 | Warnings, Adverse reactions | CEFDINIR |
| cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 2e384d98-642e-4841-9f62-fcea4c242f4e | 2026-03-24 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals, Inc. | 8787ea15-bf90-4178-9b0f-08b075f1aa3d | 2026-03-24 | Warnings | CEFDINIR |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals,Inc. | c23af6af-a97b-b98d-e053-2995a90ae780 | 2026-03-13 | Warnings, Adverse reactions | CEFDINIR |
| cefdinir | CEFDINIR | A-S Medication Solutions | 2bd2101c-511d-45a9-b1d8-a45ed40c5b80 | 2026-03-12 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | PD-Rx Pharmaceuticals, Inc. | a5f028d5-ab33-491e-a385-56e79e165150 | 2026-02-24 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | REMEDYREPACK INC. | eb354221-c476-41cb-ad87-52423f81d698 | 2026-01-28 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | AvKARE | 1acc5d17-10a4-e23d-e063-6394a90a52c3 | 2026-01-13 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | A-S Medication Solutions | 17b4e82f-4169-4ab9-bd4a-79781a71e160 | 2025-12-19 | Warnings | CEFDINIR |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals,Inc. | 9ba5cb2d-6272-27de-e053-2995a90a58c8 | 2025-12-03 | Warnings, Adverse reactions | CEFDINIR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 30415 | SUPPL | 2015-11-20 |
| 18147 | SUPPL | 2015-11-19 |
| 39220 | SUPPL | 2009-01-02 |
| 8149 | SUPPL | 2008-12-19 |
| 8148 | SUPPL | 2007-09-25 |
| 39219 | SUPPL | 2007-09-19 |
| 30414 | SUPPL | 2007-07-05 |
| 18146 | SUPPL | 2007-06-27 |
| 42709 | ORIG | 2006-01-03 |
| 30413 | SUPPL | 2005-07-21 |
| 18145 | SUPPL | 2005-07-21 |
| 30412 | SUPPL | 2004-09-03 |
| 8147 | SUPPL | 2002-07-24 |
| 39218 | SUPPL | 1999-11-24 |
| 30411 | SUPPL | 1999-11-24 |